Robert Edward Schwartz

Robert Edward Schwartz, M.D., Ph.D. is an Associate Professor of Medicine at Weill Cornell Medical College and an Attending Physician at New York-Presbyterian Hospital's Cornell campus. A graduate of Cooper Union (B.E. 1999), University of Minnesota (M.D. and Ph.D. 2006), he completed Internal Medicine residency at Barnes-Jewish Hospital and Gastroenterology/Hepatology fellowship at Brigham and Women's Hospital. His clinical focus includes liver diseases such as viral hepatitis, autoimmune hepatitis, and metabolic liver disorders.

• Education:
  • B.E., Chemical Engineering, Cooper Union (1999)
  • M.D. and Ph.D., Biomedical Engineering, University of Minnesota (2006)

Dr. Schwartz's research develops human liver disease models in vitro using stem cell biology and engineering techniques. His work spans:

• Hepatitis B and C pathogenesis
• Organoid modeling for viral infections
• Extracellular vesicle roles in metastasis
• Liver zonation and metabolic dysfunction
• Spaceflight-induced mitochondrial stress
• COVID-19 systemic effects

He holds advisory roles at Lime Therapeutics and Miromatrix Medical Inc., with prior consultation at Alnylam Pharmaceuticals. Active grants include NIH/NIDDK-funded research on epithelial-mesenchymal crosstalk in liver disease and NASA collaborations on spaceflight countermeasures.